Tandem Diabetes Care

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNDM and other ETFs, options, and stocks.

About TNDM

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. 

CEO
John F. Sheridan
CEOJohn F. Sheridan
Employees
2,650
Employees2,650
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2006
Founded2006
Employees
2,650
Employees2,650

TNDM Key Statistics

Market cap
1.44B
Market cap1.44B
Price-Earnings ratio
-6.98
Price-Earnings ratio-6.98
Dividend yield
Dividend yield
Average volume
3.01M
Average volume3.01M
High today
$21.48
High today$21.48
Low today
$19.35
Low today$19.35
Open price
$19.57
Open price$19.57
Volume
3.19M
Volume3.19M
52 Week high
$38.28
52 Week high$38.28
52 Week low
$9.98
52 Week low$9.98

Stock Snapshot

Tandem Diabetes Care(TNDM) stock is priced at $21.28, giving the company a market capitalization of 1.44B. It carries a P/E multiple of -6.98.

On 2025-11-23, Tandem Diabetes Care(TNDM) stock traded between a low of $19.35 and a high of $21.48. Shares are currently priced at $21.28, which is +10.0% above the low and -0.9% below the high.

Tandem Diabetes Care(TNDM) shares are trading with a volume of 3.19M, against a daily average of 3.01M.

In the last year, Tandem Diabetes Care(TNDM) shares hit a 52-week high of $38.28 and a 52-week low of $9.98.

In the last year, Tandem Diabetes Care(TNDM) shares hit a 52-week high of $38.28 and a 52-week low of $9.98.

TNDM News

Simply Wall St 1d
Why Tandem Diabetes Care Is Up 14.3% After FDA Clears Android App for Mobi System and What’s Next

Tandem Diabetes Care recently announced that the U.S. Food and Drug Administration has cleared the Android version of the Tandem Mobi mobile app, with limited r...

Why Tandem Diabetes Care Is Up 14.3% After FDA Clears Android App for Mobi System and What’s Next
Simply Wall St 6d
Tandem Diabetes Care: How a Device Correction and Legal Scrutiny Shape Valuation Prospects

Tandem Diabetes Care (TNDM) shares took a sharp hit after the company announced a voluntary medical device correction for certain t:slim X2 insulin pumps. This...

Tandem Diabetes Care: How a Device Correction and Legal Scrutiny Shape Valuation Prospects

Analyst ratings

64%

of 25 ratings
Buy
32%
Hold
64%
Sell
4%

People also own

Based on the portfolios of people who own TNDM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.